186 related articles for article (PubMed ID: 23552285)
1. Distinct patterns of histone modifications at cardiac-specific gene promoters between cardiac stem cells and mesenchymal stem cells.
Wang M; Yu Q; Wang L; Gu H
Am J Physiol Cell Physiol; 2013 Jun; 304(11):C1080-90. PubMed ID: 23552285
[TBL] [Abstract][Full Text] [Related]
2. DNA methyltransferases inhibitors effectively induce gene expression changes suggestive of cardiomyogenic differentiation of human amniotic fluid-derived mesenchymal stem cells via chromatin remodeling.
Gasiūnienė M; Zentelytė A; Wojtas B; Baronaitė S; Krasovskaja N; Savickienė J; Gielniewski B; Kaminska B; Utkus A; Navakauskienė R
J Tissue Eng Regen Med; 2019 Mar; 13(3):469-481. PubMed ID: 30637987
[TBL] [Abstract][Full Text] [Related]
3. The Epigenetic Regulator HDAC1 Modulates Transcription of a Core Cardiogenic Program in Human Cardiac Mesenchymal Stromal Cells Through a p53-Dependent Mechanism.
Moore JB; Zhao J; Keith MC; Amraotkar AR; Wysoczynski M; Hong KU; Bolli R
Stem Cells; 2016 Dec; 34(12):2916-2929. PubMed ID: 27501845
[TBL] [Abstract][Full Text] [Related]
4. A role for Gcn5 in cardiomyocyte differentiation of rat mesenchymal stem cells.
Li L; Zhu J; Tian J; Liu X; Feng C
Mol Cell Biochem; 2010 Dec; 345(1-2):309-16. PubMed ID: 20835911
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase 1-mediated histone modification regulates osteoblast differentiation.
Lee HW; Suh JH; Kim AY; Lee YS; Park SY; Kim JB
Mol Endocrinol; 2006 Oct; 20(10):2432-43. PubMed ID: 16728531
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic reprogramming converts human Wharton's jelly mesenchymal stem cells into functional cardiomyocytes by differential regulation of Wnt mediators.
Bhuvanalakshmi G; Arfuso F; Kumar AP; Dharmarajan A; Warrier S
Stem Cell Res Ther; 2017 Aug; 8(1):185. PubMed ID: 28807014
[TBL] [Abstract][Full Text] [Related]
7. The genomic landscapes of histone H3-Lys9 modifications of gene promoter regions and expression profiles in human bone marrow mesenchymal stem cells.
Tan J; Huang H; Huang W; Li L; Guo J; Huang B; Lu J
J Genet Genomics; 2008 Oct; 35(10):585-93. PubMed ID: 18937915
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic reprogramming of IGF1 and leptin genes by serum deprivation in multipotential mesenchymal stromal cells.
Sanchez C; Oskowitz A; Pochampally RR
Stem Cells; 2009 Feb; 27(2):375-82. PubMed ID: 19038795
[TBL] [Abstract][Full Text] [Related]
9. Trichostatin a promotes cardiomyocyte differentiation of rat mesenchymal stem cells after 5-azacytidine induction or during coculture with neonatal cardiomyocytes via a mechanism independent of histone deacetylase inhibition.
Yang G; Tian J; Feng C; Zhao LL; Liu Z; Zhu J
Cell Transplant; 2012; 21(5):985-96. PubMed ID: 21944777
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: insights for driven maturation and hypertrophic growth.
Chow MZ; Geng L; Kong CW; Keung W; Fung JC; Boheler KR; Li RA
Stem Cells Dev; 2013 Oct; 22(19):2678-90. PubMed ID: 23656529
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of HDAC1 is involved in the cardiomyocyte differentiation from mesenchymal stem cells in a myocardial microenvironment.
Lu DF; Yao Y; Su ZZ; Zeng ZH; Xing XW; He ZY; Zhang C
PLoS One; 2014; 9(4):e93222. PubMed ID: 24690943
[TBL] [Abstract][Full Text] [Related]
12. Histone modifications interact with DNA methylation at the GATA4 promoter during differentiation of mesenchymal stem cells into cardiomyocyte-like cells.
Xu H; Yi Q; Yang C; Wang Y; Tian J; Zhu J
Cell Prolif; 2016 Jun; 49(3):315-29. PubMed ID: 27117983
[TBL] [Abstract][Full Text] [Related]
13. Islet-1 synergizes with Gcn5 to promote MSC differentiation into cardiomyocytes.
Xu H; Zhou Q; Yi Q; Tan B; Tian J; Chen X; Wang Y; Yu X; Zhu J
Sci Rep; 2020 Feb; 10(1):1817. PubMed ID: 32019948
[TBL] [Abstract][Full Text] [Related]
14. In vitro epigenetic reprogramming of human cardiac mesenchymal stromal cells into functionally competent cardiovascular precursors.
Vecellio M; Meraviglia V; Nanni S; Barbuti A; Scavone A; DiFrancesco D; Farsetti A; Pompilio G; Colombo GI; Capogrossi MC; Gaetano C; Rossini A
PLoS One; 2012; 7(12):e51694. PubMed ID: 23284745
[TBL] [Abstract][Full Text] [Related]
15. Regulation of osteogenesis in bone marrow-derived mesenchymal stem cells via histone deacetylase 1 and 2 co-cultured with human gingival fibroblasts and periodontal ligament cells.
Iwata T; Kaneda-Ikeda E; Takahashi K; Takeda K; Nagahara T; Kajiya M; Sasaki S; Ishida S; Yoshioka M; Matsuda S; Ouhara K; Fujita T; Kurihara H; Mizuno N
J Periodontal Res; 2023 Feb; 58(1):83-96. PubMed ID: 36346011
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic upregulation of urokinase plasminogen activator promotes the tropism of mesenchymal stem cells for tumor cells.
Pulukuri SM; Gorantla B; Dasari VR; Gondi CS; Rao JS
Mol Cancer Res; 2010 Aug; 8(8):1074-83. PubMed ID: 20663859
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential.
Siegel G; Krause P; Wöhrle S; Nowak P; Ayturan M; Kluba T; Brehm BR; Neumeister B; Köhler D; Rosenberger P; Just L; Northoff H; Schäfer R
Stem Cells Dev; 2012 Sep; 21(13):2457-70. PubMed ID: 22309203
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor induction of P-glycoprotein transcription requires both histone deacetylase 1 dissociation and recruitment of CAAT/enhancer binding protein beta and pCAF to the promoter region.
Kim SN; Kim NH; Lee W; Seo DW; Kim YK
Mol Cancer Res; 2009 May; 7(5):735-44. PubMed ID: 19435809
[TBL] [Abstract][Full Text] [Related]
19. The DnaJ-related factor Mrj interacts with nuclear factor of activated T cells c3 and mediates transcriptional repression through class II histone deacetylase recruitment.
Dai YS; Xu J; Molkentin JD
Mol Cell Biol; 2005 Nov; 25(22):9936-48. PubMed ID: 16260608
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic mechanisms in the dopamine D2 receptor-dependent inhibition of the prolactin gene.
Liu JC; Baker RE; Chow W; Sun CK; Elsholtz HP
Mol Endocrinol; 2005 Jul; 19(7):1904-17. PubMed ID: 15731170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
